98%
921
2 minutes
20
Background And Aims: The burden of cardiometabolic multimorbidity (CMM) in hypertensive patients is substantial, and obesity may play an important role in progression of CMM. We aim to explore associations of obesity with the transition patterns from hypertension to first cardiometabolic disease (FCMD), CMM, and death.
Methods And Results: 21 286 hypertensive patients over 40 were enrolled in Yinzhou Health Information System from 2010 to 2015, followed until June 30, 2022. CMM was defined as the coexistence of stroke, diabetes, and coronary heart disease. Two indices of obesity including body mass index (BMI) and waist circumference (WC) were assessed at baseline. We used multi-state models to evaluate associations of BMI and WC between risk of CMM trajectories in hypertensive patients. During a median follow-up of 8.06 years, 13 289 hypertensive patients developed CMD, 6401 further developed CMM, and 1648 died. WC in every 1 cm increase was positively associated with risk of transitions from hypertension to FCMD (HR = 1.01, 95 % CI: 1.00-1.01) and from FCMD to CMM (HR = 1.01, 95 % CI: 1.01-1.02). Underweight participants had a 17 % elevated risk of transition from FCMD to CMM, while overweight participants had a 5 % elevated risk of transition from hypertension to FCMD. U-shape curves were observed for the association of WC with transitions from FCMD or CMM to death.
Conclusions: Underweight and abnormal WC were associated with an increased risk of CMM and death in hypertensive patients. Our findings emphasize the role of healthy body shape in hypertensive management.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.numecd.2025.103851 | DOI Listing |
BMC Health Serv Res
September 2025
Center for Health Services Research, Brandenburg Medical School Theodor Fontane, Seebad 82/83, Rüdersdorf, 15562, Germany.
Background: Hypertension remains a critical public health issue in Germany, affecting millions of individuals. Mobile health applications (mHealth apps) offer promising solutions for improving patient outcomes and adherence in hypertension management. Despite their advantages in healthcare, the adoption of mHealth apps by general practitioners (GPs) in Germany remains limited to date.
View Article and Find Full Text PDFBMC Psychiatry
September 2025
Department of Cardiovascular, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Jiangxi, Nanchang, 330006, China.
World J Urol
September 2025
Bichat Claude Bernard Hospital, Public Assistance of Paris Hospitals, Paris, France.
Purpose: Screening and diagnosing ISUP ≥ 2 prostate cancer is challenging. This study aimed to determine whether canine detection could be beneficial addition to the ISUP ≥ 2 prostate cancer diagnostic protocol by creating a decision-making algorithm for men with suspected prostate cancer.
Methods: We conducted a prospective study at two urology institutions and a French veterinary school, including men with a suspicion of prostate cancer from November to April 2023, which were divided into two groups according to their prostate biopsy results.
Arch Bronconeumol
September 2025
Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Intern Med
September 2025
Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Japan.